Other Clinical Trial - The British Heart Foundation SENIOR-RITA Trial

Status Active, not recruiting

Clinical Trial Summary

SENIOR-RITA is a multicentre prospective open-label trial randomizing patients presenting with type 1 NSTEMI aged ≥75 years between invasive and conservative treatment strategies, to compare time from randomisation to cardiovascular death or non-fatal MI

Clinical Trial Description

The population is getting older and heart artery disease is the biggest killer in the UK. Over recent years, there have been improvements in medications and technologies to treat it, but these have been primarily tested in younger patients. Previous research studies suggest that older patients (75 years and over) are not well represented in clinical research and these patients in particular those that are frail and those with co-morbidities are less likely to receive advanced medications and medical procedures. The current study will enrol patients 75 years and over, presenting with a heart attack. If patients agree to participate, they will be randomly allocated to one of two treatment groups. In the first group, patients will receive the latest medications recommended in heart attack. In the second group, in addition to these medications, patients will have coronary angiography. This will show whether they have any blockages in heart arteries. If appropriate, coronary revascularisation by percutaneous coronary intervention (PCI) commonly known as coronary angioplasty or coronary artery bypass grafting, sometimes called CABG (a surgical procedure in which a blood vessel from the leg, arm or chest is used to bypass a narrowed section of a coronary artery) will be carried out. During the trial, frailty scores, cognition measures, co-morbidity indices, questionnaires on quality of life, NHS and personal social services utilization will be collected from the participant and in addition proxy quality of life information will be collected from the participant's carers. Investigators will evaluate which one of the two treatment groups will do better and live longer. Investigators will also collect information on their quality of life and frailty measures for a 5 year period. The trial hopes to recruit 2300 patients from approximately 30 centres across the UK. ;

Study Design

Related Conditions & MeSH terms

NSTEMI - Non-ST Segment Elevation MI

Clinical Trial Details

NCT number	NCT03052036
Study type	Interventional
Source	Newcastle-upon-Tyne Hospitals NHS Trust
Contact
Status	Active, not recruiting
Phase	N/A
Start date	November 2016
Completion date	March 2024

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT04951856` - Evolocumab or Normal Strategies to Reach LDL Objectives in Acute Myocardial Infarction Upbound to PCI	Phase 4
Completed	`NCT03103620` - Safety and Effectiveness Evaluation of COBRA PzF Coronary Stent System: A Post Marketing Observational Registry
Completed	`NCT04648306` - Restore EF Observational Study
Recruiting	`NCT06095557` - MCG Discovery Study in Emergency Departments	N/A
Not yet recruiting	`NCT04403048` - Drug Coated Balloon for Side Branch Treatment vs. Conventional Approach in True Bifurcation Coronary Disease: PRO-DAVID	N/A
Completed	`NCT03489603` - Clinical and Economic Outcomes of High Sensitivity Troponin for no ST Elevation Myocardial Infarction in Patients With Chest Pain in Emergency Departments in Italy-An Observational Study
Recruiting	`NCT04140019` - Early Cardiac Magnetic Resonance Imaging in Suspected Non-ST-Elevation Myocardial Infarction
Completed	`NCT04289012` - HELicobacter Pylori Screening in Patients With Acute Myocardial Infarction Pilot Study	N/A
Completed	`NCT02983123` - One-hour Troponin in a Low-prevalence Population of Acute Coronary Syndrome
Completed	`NCT03943966` - In-vivo Thrombus Imaging With 18F-GP1, a Novel Platelet PET Radiotracer	N/A
Completed	`NCT03677180` - National Cardiogenic Shock Initiative
Completed	`NCT03507777` - ILUMIEN IV: OPTIMAL PCI	N/A
Recruiting	`NCT03863327` - EKG Criteria and Identification of Acute Coronary Occlusion
Completed	`NCT03461484` - e-BioMatrix 6 Month DAPT France
Recruiting	`NCT03089450` - To Evaluate Safety and Efficacy of CGBIO Stent Compared to Biomatrix Flex Stent	N/A
Active, not recruiting	`NCT04090281` - Implementing Precision Medicine Approaches to Guide Anti-platelet Selection	Phase 4
Recruiting	`NCT03562572` - FFR Driven Complete Revascularization Versus Usual Care in NSTEMI Patients and Multivessel Disease	N/A
Completed	`NCT03822377` - Ticagrelor Administered as Standard Tablet or Orodispersible Formulation	Phase 3
Recruiting	`NCT04002739` - PRedictOrs, PHEnotypes and Timing of Obstructive Sleep Apnea in Acute Coronary Syndrome	N/A
Completed	`NCT03111862` - Safety of Accelerated Rule-out Protocols in Patients Admitted With Chest Pain to a Crowded Chest Pain Unit (CPU)

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

The British Heart Foundation SENIOR-RITA Trial — SENIOR-RITA

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms